Exhalation delivery system with fluticasone improves quality of life and health status: pooled analysis of phase 3 trials NAVIGATE I and II.
Zachary M SolerSam ColmanFulton F VelezRodney J SchlosserPublished in: International forum of allergy & rhinology (2020)
In this pooled analysis of 2 large pivotal EDS-FLU trials, health domain and health utilities improvements were significantly greater with EDS-FLU than EDS-PBO and were comparable to population norms.